Skip to main content
. Author manuscript; available in PMC: 2020 Feb 23.
Published in final edited form as: J Cardiovasc Nurs. 2017 Nov-Dec;32(6):530–537. doi: 10.1097/JCN.0000000000000407

Table 1.A.

Baseline Characteristics (Sociodemograhic)

All
Participants
(N=71)
Group 1a
(n = 19)
Group 2b
(n = 16)
Group 3c
(n = 9)
Group 4d
(n = 27)
P value
Age, years (Mean±SD) 55.56 ± 11.13 55.21 ± 10.75 55.50 ± 12.51 56.33 ± 11.41 55.59 ± 11.09 .996
Male, N (%) 47 (66.2%) 13 (68.4%) 10 (62.5%) 6 (66.7%) 18 (66.7%) .986
Race, N (%) .298
 Hispanic 10 (14.1%) 5 (26.3%) 2 (12.5%) 1 (11.1%) 2 (7.4%)
 White 47 (66.2%) 11 (57.9%) 9 (56.3%) 8 (88.9%) 19 (70.4%)
 African America 14 (19.7%) 3 (15.8%) 5 (31.3% 0 (0%) 6 (22.2%)
Married, N (%) 43 (60.6%) 10 (52.6%) 9 (56.3%) 8 (88.9%) 16 (59.3%) .300
Employed, N (%) 20 (28.3%) 7 (36.8%) 3 (18.8%) 2 (22.2%) 8 (29.6%) .661
Education, N (%) .086
 < 12 26 (26.6%) 2 (7.7%) 7 (26.9%) 3 (11.5%) 14 (53.8%)
 12-16 29 (40.8%) 10 (34.5%) 7 (24.1%) 5 (17.2%) 7 (24.1%)
 > 16 16 (22.1%) 7 (43.8%) 2 (12.5%) 9 (12.7%) 6 (37.5%)
a

Group 1: participants with improvements in peak VO2 greater that 10%

b

Group 2: participants with improvements in peak VO2 less than 10%

c

Group 3: participants with reductions in peak VO2 less than 10%

d

Group 4: participants with reductions in peak VO2 greater that 10%